Objective: Intermediate/long-term results after aortic valve replacement using bileaflet mechanical valve in children should be clarified as a standard of treatment of aortic valve disease in children. Methods: Forty-five patients aged under 15 years underwent 46 aortic valve replacements using bileaflet mechanical prosthetic valve. Patients' ages ranged from 1 to 15 years (9 years as a median value), and follow-up period was 9.2 years as a median value (maximum 19 years). Results: In situ valve replacement was performed in 21 procedures, while annular enlargement was required in 25 procedures (Nicks 10, Yamaguchi 3, Manouguian 2, Konno 10). All patients except two received prosthesis 19 mm or larger in size. There was one operative death and two late deaths. Two episodes of cerebral infarction, two valve thrombosis, two reoperations, one infective endocarditis, and one sudden death were recognized as valve-related complications in five patients. The reasons for reoperation were prosthesis-patient mismatch in one (Ross procedure) and valve thrombosis in one (re-replacement). At 15 years after the operation, re-replacement free rate, valve-related event free rate and actuarial survival rate were 94 AE 4%, 86 AE 6% and 92 AE 4%, respectively. The transprosthetic flow velocity estimated by Doppler echocardiography at the final follow-up was well correlated with manufactured valve area index (cm 2 /body surface area). Conclusions: Although aortic annular enlargement was required in more than half of the cases, intermediateterm results after aortic valve replacement using bileaflet mechanical prosthetic valve in children was satisfactory. Indications for alternative treatment such as Ross procedure might be considered in limited cases. #
Introduction
Aortic valve procedure in children is sometimes necessary not only for congenital malformation of the aortic valve but also many kinds of cardiac malformations such as aortic valve deformation associated with ventricular septal defect, deterioration of the neo aortic valve after the arterial switch operation for the transposition of the great arteries, and so on. Although numerous efforts by cardiac surgeons have been made to repair the pathological regions of the aortic valve, reparative procedure of the aortic valve is not always feasible. The selection of the most appropriate substitute for the aortic position in children is still controversial.
There are four types of substitutes available for the aortic position at the moment. Porcine bioprosthesis and bovine pericardial bioprosthesis are considered to be good substitutes for elderly people because of their excellent antithrombogenesity, while they are considered unsuitable for children because of their poor durability in young patients [1] [2] [3] [4] . Allograft has been implanted especially in small children because of its variety of size, excellent antithrombogenesity and good flexibility. However, allograft also has the disadvantage of limited durability due to early calcification in young recipients and limited availability in the market [3, 5] . Mechanical valve requires lifelong cumbersome anticoagulation, while it shows an excellent long-term performance with relatively low incidence of complication in children [4, 6, 7] .
There has been increasing enthusiasm for pulmonary autograft (Ross procedure) for aortic valve replacement in children and adolescents. It shows good hemodynamic performance, freedom of anticoagulation and hemolysis, and is considered to have the ability to grow [3, 4, [8] [9] [10] [11] . However, in addition to the complexity of the insertion technique and the creation of a new pathology in the normal right ventricular outflow tract, long-term performance of the pulmonary valve in the systemic circulation is still unknown.
In the process of the selection of a substitute for the aortic position in children, not only surgical outcomes but also longterm results should be considered carefully. In this study, we retrospectively analyzed our intermediate-term outcome of recent bileaflet mechanical prosthetic valve replacement at the aortic position in children.
Patients and methods
Between 1988 and 2006, 45 children under age of 15 years underwent 46 aortic valve replacements using bileaflet mechanical prosthetic valves at the Fukuoka Children Hospital or at the Kyushu University Hospital. Age at the time of implantation of the prosthesis ranged from 1 year to 15 years (median, 9 years of age), and body weight ranged from 5.3 kg to 70 kg (median, 31.9 kg). There were 32 males and 13 females. Valve pathology was aortic regurgitation in 25 cases, aortic stenosis in 11 cases, and combination of aortic regurgitation and stenosis in 9 cases. Twenty patients underwent 31 previous cardiac procedures (Table 1 Table 2 ). The selection of prosthesis was dependent on the patient's aortic annular size and situation of the Japanese market and surgeon's preference. Thirty-two patients underwent 39 concomitant procedures including 25 aortic annular enlargements (Nicks procedure [12] in 10, Yamaguchi procedure [13] in 3, Manouguian procedure [14] in 2 and Konno procedure [15] in 10) ( Table 3) .
Postoperative anticoagulation was achieved by intravenous administration of heparin sodium (400 U/kg per day), with subsequent oral intake of aspirin (5 mg/kg per day) until 1998, and oral intake of warfarin potassium in a dosage to maintain the value of Thrombotest within the range between 10% and 20% (a prothrombin time-international normalized ratio level between 2.5 and 1.8) since 1998.
Patients' follow-up was done either by referencing patients' hospital records or through direct telephone calls. Follow-up period ranged from 1 month to 19.1 years (median; 9.2 years) with complete follow-up rate of 95%. Thirty-seven Doppler echocardiography images including the value of transprosthetic flow velocity were obtained within a 1-year period before the final follow-up. The definition of the events during the follow-up was according to the guideline for reporting valve-related mortality and morbidity after cardiac valvular operations by Edmunds et al. [16] .
All data in the text are expressed as the mean AE standard deviation. Time-related changes in survival, freedom from re-replacement of aortic valve and valve-related events were analyzed with the Kaplan-Meier method. Statistical analysis was made using StatView software (Abacus Concept, Inc, Berkeley, CA). A p-value equal or less than 0.05 was considered statistically significant.
Results
Fig . 1 shows the size of the prosthesis and the types of annular enlargement plotted by body weight at the time of There was one operative death. This patient was diagnosed as truncus arteriosus with single coronary artery, and previously had undergone Rastelli type procedure with external conduit between the right ventricle to the pulmonary artery. She underwent aortic valve replacement using Nicks procedure for annular enlargement associated with conduit replacement at 7 years of age. We lost her in spite of the application of postoperative circulatory support for severe postoperative heart failure. There were two late deaths. The reason for late death was sudden death in one patient 6 years after the in situ aortic valve replacement using St. Jude Medical valve Hemodynamic Plus series 19 mm. Autopsy revealed neither apparent evidence of cerebral infarction nor intrinsic/extrinsic structural valve deterioration. The other patient died due to heart failure 5 months after the aortic valve replacement using St. Jude Medical valve Hemodynamic Plus series 21 mm with Nicks procedure.
As valve-related complications, two episodes of cerebral infarction, two valve thrombosis, two re-replacement of aortic valve, one infective endocarditis, and one sudden death were recognized in five patients. Cerebral infarction occurred in one patient at 1998 when our anticoagulation regimen was aspirin only. After changing our anticoagulation regimen to warfarin, one cerebral infarction was recognized due to withdrawal of warfarin by patient himself. Valve thrombosis occurred twice in the same patient with a therapeutic level of anticoagulation with warfarin. Thrombolysis was successful at the first time (4 years after the aortic valve replacement), while re-replacement of the aortic valve was required at the second time (4.8 years after the aortic valve replacement). Pannus formation under the prosthesis was also observed at the time of re-replacement. Another patient, who had St. Jude Medical valve Hemodynamic Plus series 17 mm with Yamaguchi procedure, required a Ross-Konno procedure 8 years after the initial aortic valve replacement due to prosthesis-patient mismatch associated with pannus formation.
Actuarial survival rate was 92 AE 4% at 15 years after the initial aortic valve replacement with bileaflet mechanical valve. Freedom from re-replacement of aortic valve and valve-related events was 94 AE 4% and 86 AE 6% at 15 years, respectively (Fig. 2) .
Maximum transprosthetic flow velocity (V max ) estimated by follow-up Doppler echocardiography was well correlated with prosthetic valve orifice area index (manufactured geometric prosthetic valve area divided by patient's body surface area) at the time of examination (V max = À67.9 Â valve orifice area index + 338.5; r = 0.33; p = 0.043; Fig. 3 ). V max remained under 300 cm/s in all patients with manufactured valve area index over 1.0 cm 2 /m 2 except for two who required rereplacement of aortic valve due to pannus formation associated with valve thrombosis or prosthesis-patient mismatch. Their V max exceeded 400 cm/s at the time of rereplacement.
Discussion
Although there has been increasing interest in the pulmonary autograft implantation at the aortic position (Ross procedure) in children and adolescents, there are still controversies regarding the selection of substitutes at the aortic position in children.
Porcine bioprosthesis and bovine pericardial bioprosthesis do not require permanent anticoagulation, however, they have been almost abandoned for clinical use in small children because of their very early degeneration, calcification and structural failure in young recipients [1] [2] [3] [4] . Allograft allows implantation of small size substitutes for neonates and infants, in addition there is the unnecessity of anticoagulation and excellent freedom from anticoagulationrelated complications. However, allograft shares the same disadvantage of limited durability as xenograft has [3, 5] .
Pulmonary autograft (Ross procedure) has become the first choice of aortic valve replacement in children and adolescents in some institutes [3, 4, [8] [9] [10] [11] . Pulmonary autograft shows excellent hemodynamic performance, freedom of anticoagulation and hemolysis, and decreased susceptibility to endocarditis. Pulmonary autograft is also known to have the potential for growth. However, the Ross procedure is a technically demanding procedure, and reoperation for bleeding and postoperative conduction abnormality is not as rare as early complications [11] . Freedom from autograft dysfunction including autograft insufficiency 3+ or more ranges from 75% to 100% depending upon the duration of follow-up [11] . Elkins et al. [17] reported freedom from autograft replacement of 93% and freedom from severe autograft insufficiency or valve-related death of 90% at their 12-year follow-up. The autograft insufficiency is one of the leading cause of reoperation in Ross procedure, and several factors are implicated as risk factors such as preoperative diagnosis of aortic insufficiency, presence of dilated aortic annulus, bicuspid aortic valve, rheumatic heart disease, technical imprecision, the type of insertion, inherent disease of the pulmonary valve, and so on [11] .
Elkins et al. [17] reported a freedom from right ventricular outflow tract homograft replacement of 90% at 12 years for children. Rates of freedom from right ventricular outflow tract obstruction were also similar for several authors [18] [19] [20] [21] . Because of the diminishing availability of homograft, several conduits are used to reconstruct the right ventricular outflow tract, however, their durability seems to be worse than homograft [11] . Finally, Elkins et al. [17] reported freedom from all valve-related morbidity at 79% at 11 years.
Aortic valve replacement using mechanical prosthetic valves in children often require annular enlargement to insert commercially available prosthesis [6, 7] . Nicks procedure [12] enables insertion of prosthesis one size bigger than that of in situ insertion, while Konno procedure [15] , Manouguian procedure [14] and Yamaguchi procedure [13] enable insertion of prosthesis two sizes bigger than that of in situ insertion. Konno procedure requires incision of the ventricular septum that might cause ventricular dysfunction or conduction abnormality. In Manouguian procedure, the incision is extended to the anterior mitral leaflet that might cause the mitral insufficiency. Yamaguchi procedure is now our choice of procedure because it does not damage either ventricular septum or mitral leaflet.
Our institutional anticoagulation strategy changed from aspirin to warfarin since 1998 when we had cerebral infarction in one patient. Since we started the new anticoagulation strategy with warfarin, we have not seen any thrombo-embolic events except for two cases, one valve thrombosis associated with pannus formation and the other with cerebral infarction due to warfarin withdrawal by the patient himself. There was no major anticoagulation related hemorrhage. Our freedom from anticoagulationrelated events (thrombo-embolism and hemorrhage) at 15 years was 92 AE 4%.
In our study, all patients except for two received bileaflet mechanical prosthetic valve 19 mm or larger in size along with our vigorous application of annular enlargement at the time of initial implantation. Effective valve orifice area index less than 0.85 cm 2 /m 2 is now considered as a criterion of prosthesis-patient mismatch in adults [22] , while effective valve orifice area of the prosthesis is different by researchers. In this study, we measured transprosthetic flow velocity by Doppler echocardiography, and plotted these data according to the manufactured valve area index. This revealed that transprosthetic flow velocity does not exceed 300 cm/s in cases with manufactured valve area index more than 1.0 cm 2 /m 2 except for cases associated with pannus formation. It means that, at least in most of our Japanese patients with small body size even in adults, implantation of St. Jude Medical Regent series 19 mm whose manufactured valve area is 2.39 cm 2 may not require further re-replacement of the aortic valve unless massive pannus formation develops. Our speculation was compatible with the result of Shanmugan et al. [7] who reported no rereplacement of prosthesis required when the patient received a prosthesis 21 mm or larger in size. The impact of residual pressure gradient across the prostheses on longterm performance of the myocardium is still controversial. Freedom from re-replacement of aortic valve in our series was 94 AE 4% at 15 years, and was at least compatible with the results of other series with mechanical prosthesis by Shanmugan et al. [7] (92% at 20 years), Alexiou et al. [6] (86.4% at 20 years) and Ruzmetov et al. [4] (84% at 19 years), and was not inferior to the results of pulmonary autograft reported by Elkins et al. [17] (93% at 12 years), Turrentine et al. [2] (88% at 7 years), Laudito et al. [23] (83% at 6.6 years) and Pasquali et al. [21] (81% at 8 years). Actuarial survival rate of 92 AE 4% and freedom from valve related complications of 86 AE 6% at 15 years in our series seems quite acceptable, and these results were compatible with recent results after the Ross procedure [2, 4, 8, 19, 20, 23] . Longterm survival after the aortic valve replacement using bileaflet mechanical prosthetic valve was satisfactory, and an incident rate of late events was low.
This study is retrospective, and the number of patients is relatively small and the follow-up period is not sufficiently long to be conclusive. Our indication for re-replacement of aortic prosthetic valve has not been well established, although left ventricular outflow tract gradient by Doppler echocardiography greater than 40 mmHg [24] is our indication of re-replacement at this moment. Regardless of these limitations, we believe that our study gives useful information to the surgeons to decide their strategy for aortic valve replacement in children.
In conclusion, intermediate-term clinical results of aortic valve replacement in children using bileaflet mechanical prosthetic valve with aortic annular enlargement if necessary was satisfactory. Good hemodynamic performance of recent commercially available bileaflet mechanical prosthetic valve might avoid further re-replacement of the aortic prosthetic valve. Indication of pulmonary autograft insertion at the aortic position, Ross procedure, might be considered carefully in limited cases such as neonate and infants. Dr G. Sarris (Athens, Greece): Before we move on, just a last comment and a brief question. This is an important paper showing very good results of mechanical valve replacement in children. This is a very important contribution, especially given the increasing awareness of long-term problems with root dilatation after the Ross operation. Given these results from your unit, what is your policy now with performing the Ross operation in children? Is there a place for the Ross operation in your practice?
Dr Masuda: It's different for each surgeon, but I myself, I think very small patients, like neonates and infants, might be the candidates for the Ross operation.
